VKH
ADVM

Virtu KCG Holdings’s Adverum Biotechnologies ADVM Stock Holding History

Virtu KCG Holdings’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$144K Buy
+5,763
New +$158K ﹤0.01% 2315
2017
Q1 		– Sell
-1,995
Closed -$58K – 3077
2016
Q4 		$58K Buy
1,995
+789
+65% +$25.8K ﹤0.01% 3058
2016
Q3 		$50K Buy
+1,206
New +$45.8K ﹤0.01% 2780

Other funds holding ADVM

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu KCG Holdings's ADVM Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Adverum Biotechnologies (ADVM) in Q2 2017: 5,763 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #2315 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in ADVM as recently as Q4 2016.

Virtu KCG Holdings first reported a position in ADVM in Q3 2016 and has held it in 3 quarters since. 63 funds tracked by Wall St. Rank hold ADVM as of Q2 2017.

  • Virtu KCG Holdings held 5,763 shares of Adverum Biotechnologies worth $144K as of Q2 2017.
  • Adverum Biotechnologies was a new Virtu KCG Holdings position in Q2 2017.
  • Adverum Biotechnologies made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2315 holding.
  • Virtu KCG Holdings first reported a position in Adverum Biotechnologies in Q3 2016 and has held it in 3 quarters since.
  • 63 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.